510(k) Report

FDA applicant

Vitrolife Sweden AB

Washington, DC38 decisions2000–20251 recall

FDA records 38 decisions for Vitrolife Sweden AB (Washington, DC) from 2000 to 2025: 38 510(k) clearances. Most are in product codes MQL (Media, Reproductive) and MQE (Needle, Assisted Reproduction). Since 2016 its 510(k)s took a median of 156 days from receipt to decision, against 195 for FDA’s reviews in the same codes and years. Its devices cite 27 predicates, 12 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, obstetrics and gynecology panel, where it files most

How often FDA has decided Vitrolife Sweden AB’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2008: 62009: 22010: 12012: 12014: 12015: 12017: 22019: 22021: 12024: 22025: 1
2007high 6 (2008) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Vitrolife Sweden AB by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Vitrolife Sweden AB’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Vitrolife”

FDA records each applicant name separately; these may or may not be the same firm.